New drug improves abnormalities associated with metabolic syndrome

A newly developed drug for treating metabolic syndrome safely reduces plasma triglycerides and LDL cholesterol, and reverses NAFLD and liver insulin resistance, according to a study published in Science Translational Medicine.

MedicalXpress

Subscribe to our email alerts